Personal information

Emails & domains

Verified email addresses

Verified email domains

Activities

Collapse all

Works (7)

Enhanced hepatitis B virus–specific immunity by combining neutralizing antibody therapy and DNA vaccination in a murine model of chronic hepatitis B virus infection

Hepatology
2024-12-09 | Journal article
DOI: 10.1097/HEP.0000000000001179
Contributors: Maxime Beretta; Benjamin Vesin; Yu Wei; Cyril Planchais; Pierre Rosenbaum; Malika Ait-Goughoulte; Nadège Pelletier; David Hardy; Hugo Mouquet; Maryline Bourgine
Source: check_circle
Crossref

Full eradication of pre‐clinical human papilloma virus‐induced tumors by a lentiviral vaccine

EMBO Molecular Medicine
2023-10-11 | Journal article
DOI: 10.15252/emmm.202317723
Contributors: Laëtitia Douguet; Ingrid Fert; Jodie Lopez; Benjamin Vesin; Fabien Le Chevalier; Fanny Moncoq; Pierre Authié; Trang‐My Nguyen; Amandine Noirat; Fabien Névo et al.
Source: check_circle
Crossref

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

The Journal of experimental medicine
2022-06-15 | Journal article
DOI: 10.1084/jem.20220638
PMID: 35704748
PMC: PMC9206116
Contributors: Benjamin Vesin
Source: Self-asserted source
Benjamin Vesin

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.

Molecular therapy : the journal of the American Society of Gene Therapy
2022-04-27 | Journal article
DOI: 10.1016/j.ymthe.2022.04.016
PMID: 35484842
PMC: PMC9044714
Contributors: Benjamin Vesin
Source: Self-asserted source
Benjamin Vesin

Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice

EMBO Molecular Medicine
2021-12-07 | Journal article
DOI: 10.15252/emmm.202114459
Contributors: Min‐Wen Ku; Pierre Authié; Maryline Bourgine; François Anna; Amandine Noirat; Fanny Moncoq; Benjamin Vesin; Fabien Nevo; Jodie Lopez; Philippe Souque et al.
Source: check_circle
Crossref

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.

Cell host & microbe
2020-12-16 | Journal article
DOI: 10.1016/j.chom.2020.12.010
PMID: 33357418
PMC: PMC7738935
Contributors: Benjamin Vesin
Source: Self-asserted source
Benjamin Vesin

Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers.

The Journal of experimental medicine
2020-10-01 | Journal article
DOI: 10.1084/jem.20200840
PMID: 32579155
PMC: PMC7537403
Contributors: Benjamin Vesin
Source: Self-asserted source
Benjamin Vesin
How many people are using ORCID?